EPTIS
BAM Logo

BDH - Human plasma point-of-care testing - INR control

[BDH - Contrôle biologie délocalisée - INR]

EPTIS factsheet 1578173 | Last revision 2026-06-05 | URL: https://www.eptis.bam.de/pts1578173 https://www.eptis.bam.de/pts1578173

PT provider
PT provider PROBIOQUAL PROBIOQUAL
Based in France
Language(s) French / English
Remarks
Keywords
Product groups Health care / medical devices
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
Human plasma INR -
Aims of the PT scheme
Target group of participants Laboratory medecine / clinical biologists / limited to mainland France, not including Corsica
Linked to specific legislation / standards ISO 17043 / ISO 15189
Additional, subsidiary aims validation of testing methods
Number of participants 27
Accredited or otherwise reviewed by a 3rd party

no

Operation is commissioned / requested by no
Fees and frequency
Participation fee 295 € (1st box) and 225 € (additional box) in 2026
Regularly operated Yes (4 times per year, 6 vials)
Year of first operation 2018
Contact details of the PT provider
Provider Contact person
PROBIOQUAL
7 Rue Antoine Lumière
69008 - LYON
France

Phone: +33472653490
Fax:
Web: https://www.probioqual.com https://www.probioqual.com
Dr Régine CARTIER
Phone: +33472653490
Fax:
Email: r.cartier@probioqual.com r.cartier@probioqual.com
If you find any mistakes please contact the responsible EPTIS coordinator in France, Mr Patrick Bironneau. Mr Patrick Bironneau.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5